PAI
WST icon

Pittenger & Anderson Inc’s West Pharmaceutical WST Stock Holding History

Pittenger & Anderson Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.2K Buy
190
+75
+65% +$22.9K ﹤0.01% 297
2026
Q1 		$28.8K Hold
115
– – ﹤0.01% 347
2025
Q4 		$31.6K Hold
115
– – ﹤0.01% 333
2025
Q3 		$30.2K Hold
115
– – ﹤0.01% 323
2025
Q2 		$25.2K Hold
115
– – ﹤0.01% 319
2025
Q1 		$25.7K Sell
115
-374
-76% -$103K ﹤0.01% 313
2024
Q4 		$160K Buy
489
+80
+20% +$25.2K 0.01% 231
2024
Q3 		$123K Sell
409
-2,547
-86% -$780K ﹤0.01% 263
2024
Q2 		$974K Buy
2,956
+98
+3% +$34.6K 0.04% 161
2024
Q1 		$1.13M Buy
2,858
+1,159
+68% +$429K 0.05% 149
2023
Q4 		$598K Buy
1,699
+315
+23% +$111K 0.03% 173
2023
Q3 		$519K Buy
1,384
+716
+107% +$277K 0.03% 164
2023
Q2 		$255K Buy
668
+166
+33% +$59.3K 0.01% 191
2023
Q1 		$174K Buy
502
+167
+50% +$48.8K 0.01% 210
2022
Q4 		$78.8K Sell
335
-8,611
-96% -$2.04M ﹤0.01% 250
2022
Q3 		$2.2M Buy
8,946
+550
+7% +$168K 0.13% 127
2022
Q2 		$2.54M Buy
8,396
+365
+5% +$119K 0.15% 126
2022
Q1 		$3.3M Buy
8,031
+190
+2% +$74.4K 0.16% 118
2021
Q4 		$3.68M Buy
7,841
+385
+5% +$166K 0.17% 116
2021
Q3 		$3.17M Buy
7,456
+141
+2% +$59.4K 0.16% 120
2021
Q2 		$2.63M Buy
7,315
+195
+3% +$64.4K 0.13% 131
2021
Q1 		$2.01M Buy
+7,120
New +$2.04M 0.11% 137

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pittenger & Anderson Inc's WST Position: Q2 2026 in Review

Pittenger & Anderson Inc increased its West Pharmaceutical (WST) stake by 65% in Q2 2026, buying an estimated $22.9K and bringing the position to 190 shares worth $68.2K. The position accounts for ﹤0.01% of the portfolio, ranked #297.

Pittenger & Anderson Inc first reported a position in WST in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.68M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Pittenger & Anderson Inc held 190 shares of West Pharmaceutical worth $68.2K as of Q2 2026.
  • Pittenger & Anderson Inc bought 75 West Pharmaceutical shares in Q2 2026, an estimated $22.9K.
  • West Pharmaceutical made up ﹤0.01% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #297 holding.
  • Pittenger & Anderson Inc first reported a position in West Pharmaceutical in Q1 2021 and has held it in 22 quarters since.
  • Pittenger & Anderson Inc's West Pharmaceutical position peaked at $3.68M in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.